PD-L2 Targeting Nanobody Radiotracer for PET Imaging of Solid Tumor

Summary

The objective of this study is to construct a noninvasive approach using 68Ga- Mirc415 PET/CT to detect the PD-L2 expression of tumor lesion in patients with colorectal cancer, lung cancer and other solid tumor to identify patients benefiting from anti-PD-(L)1 treatment.

Timeline

Start

2022-07-15

Primary completion

2024-07-15

Completion

2024-07-15

Drugs

Indications